# Belgian Study to Assess the Efficacy and Safety of the RESTORER Iliac Stent for Treatment of Aorto-iliac Lesions.

Study · id `cardio:ct-nct05293002` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05293002](<https://clinicaltrials.gov/study/NCT05293002>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05293002

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 131 participants.

## Technical summary

Registry record NCT05293002. Allocation not applicable; no masking; primary purpose treatment. Start 2022-06-13 (actual); primary completion 2025-07-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 131 participants (planned count; ClinicalTrials.gov record NCT05293002, source copy `cardio:ctgov-nct05293002-2024-10-16`, retrieved 2026-11-18)
- Started: 2022-06-13 (actual) (ClinicalTrials.gov record NCT05293002, source copy `cardio:ctgov-nct05293002-2024-10-16`, retrieved 2026-11-18)
- Primary completion: 2025-07-31 (anticipated) (ClinicalTrials.gov record NCT05293002, source copy `cardio:ctgov-nct05293002-2024-10-16`, retrieved 2026-11-18)
- Completion: 2025-12-31 (anticipated) (ClinicalTrials.gov record NCT05293002, source copy `cardio:ctgov-nct05293002-2024-10-16`, retrieved 2026-11-18)
- Countries: Belgium (ClinicalTrials.gov record NCT05293002, source copy `cardio:ctgov-nct05293002-2024-10-16`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05293002-2024-10-16`, retrieved 2026-11-18)

## The registry's words

- Brief title: Belgian Study to Assess the Efficacy and Safety of the RESTORER Iliac Stent for Treatment of Aorto-iliac Lesions.
- Acronym: BARISTA
- Condition: Peripheral Arterial Disease
- Intervention (Device): Restorer Iliac Stent System
- Lead sponsor: ID3 Medical
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: ID3 Medical (`cardio:org-id3-medical`)

## Provenance

Content hash: 341966865e70444dcd0125a25d701b558a3f90b36d2ea913c76c62483ee3ac56
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
